Michael David Garrison
CIK 1944816 · EVP & Pres Med.Essntl&BioPharm · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.09M
Companies
2
Total Filings
17
Lifetime Open-Market Net
-$2.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDX | EVP & Pres Med.Essntl&BioPharm | 14,272 | $146.24 | $2.09M | -$2.75M | 15 | 2026-06-11 |
| BECTON DICKINSON & CO (BDXB) Delisted | EVP & President Medical | 6,457 | $48.16 | $311.0K | $0 | 2 | 2023-03-03 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-01 | BDX | Sell (S) | −1,715 | -$399.3K | EDGAR |
| 2024-03-05 | BDX | Tax (F) | −178 | $0 | EDGAR |
| 2023-12-12 | BDX | Sell (S) | −1,239 | -$288.0K | EDGAR |
| 2023-11-28 | BDX | Mixed | +3,356 | $0 | EDGAR |
| 2023-08-09 | BDX | Sell (S) | −1,300 | -$360.3K | EDGAR |
| 2023-03-03 | BECTON DICKINSON & CO (BDXB) Delisted | Tax (F) | −193 | $0 | EDGAR |
| 2022-11-29 | BECTON DICKINSON & CO (BDXB) Delisted | Mixed | +2,173 | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.